Seongmi Choi

Seongmi Choi

Auto-generated profile, based on publicly available information

Seongmi Choi

Health Insurance Policy Research Institute, National Health Insurance Service, Wonju, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2020 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
JKJuyeon Kang
Juyeon Kang
HKHyoungyoung Kim
Hyoungyoung Kim
JKJinwook Kim
Jinwook Kim
SCSeongmi Choi
Seongmi Choi
SJSun-Young Jung
Sun-Young Jung
YSYoon-Kyoung Sung
Yoon-Kyoung Sung

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HLHannah Lee
Hannah Lee
SCSeongmi Choi
Seongmi Choi
EJEun Jin Jang
Eun Jin Jang
JLJuhee Lee
Juhee Lee
DKDalho Kim
Dalho Kim
HRHo-Geol Ryu
Ho-Geol Ryu
Lee H, et al. J Korean Med Sci. 2021 Jul;36(34):e221. https://doi.org/10.3346/jkms.2021.36.e221

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SCSoo-Kyung Cho
Soo-Kyung Cho
SCSeongmi Choi
Seongmi Choi
HKHyoungyoung Kim
Hyoungyoung Kim
YSYeo-Jin Song
Yeo-Jin Song
SJSun-Young Jung
Sun-Young Jung
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
Cho SK, et al. J Korean Med Sci. 2022 May;37(18):e148. https://doi.org/10.3346/jkms.2022.37.e148

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
HLHannah Lee
Hannah Lee
SCSeongmi Choi
Seongmi Choi
EJEun Jin Jang
Eun Jin Jang
JLJuhee Lee
Juhee Lee
DKDalho Kim
Dalho Kim
HRHo-Geol Ryu
Ho-Geol Ryu
The purpose of this study was to evaluate whether institutional case volume affects clinical outcomes in patients receiving mechanical ventilation for 48 hours or more. We conducted a nationwide retrospective cohort study using the database of Korean National Healthcare Insurance Service. Between January 2007 and December 2016, 158,712 adult patients were included at 55 centers in Korea. Centers were categorized according to the average annual number of patients: > 500, 500 to 300, and < 300. In-hospital mortality rates in the high-, medium-, and low-volume centers were 32.6%, 35.1%, and 39.2%, respectively. After adjustment, in-hospital mortality was significantly higher in low-volume centers (adjusted odds ratio [OR], 1.332; 95% confidence interval [CI], 1.296-1.368; P < 0.001) and medium-volume centers (adjusted OR, 1.125; 95% CI, 1.098-1.153; P < 0.001) compared to high-volume centers. Long-term survival for up to 8 years was better in high-volume centers. Centers with higher case volume (> 500 patients/year) showed lower in-hospital mortality and long-term mortality, compared to centers with lower case volume (< 300 patients/year) in patients who required mechanical ventilation for 48 hours or more.

2 September 2019 in Modern Rheumatology
Verified
Journal Article
Closed access
HKHyoungyoung Kim
Hyoungyoung Kim
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
SCSeongmi Choi
Seongmi Choi
SISeul Gi Im
Seul Gi Im
SJSun-Young Jung
Sun-Young Jung
SCSoo-Kyung Cho
Soo-Kyung Cho
Objectives: To estimate risk of malignancy in patients with idiopathic inflammatory myositis (IIM) compared to patients with knee osteoarthritis (OA). Methods: Patients with IIM and knee OA aged over 50, who had no history of malignancy, were identified using Korean National claims database from January 2012 to December 2014. They had been observed until a malignancy was diagnosed or up to the end of the study, December 2015. The incidence rate (IR) of malignancy in IIM patients was calculated and compared with knee OA patients using standardized incidence ratio (SIR). Results: A total of 634 polymyositis (PM) and 556 dermatomyositis (DM) patients were included. Overall, 100 solid (IR 270.4/10,000 person-years [PY], 95% confidence interval [CI] 217.4-323.4) and 12 hematologic malignancies (IR 32.4/10,000 PY, 95% CI 14.1-50.8) occurred. Compared with knee OA, risk of overall (SIR 1.5, 95% CI 1.2-1.8), solid (SIR 1.4, 95% CI 1.1-1.6), and hematologic malignancy (SIR 5.7, 95% CI 2.5-9.0) were increased in IIM patients. This was due to increased incidence of malignancy in DM (hematologic malignancy, SIR 8.7, 95% CI 2.7-14.7, solid malignancy, SIR 1.5, 95% CI 1.1-1.9). Conclusion: Patients with IIM, especially DM, have an increased risk of malignancy compared to patients with knee OA.